Immuneering Corp (IMRX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $240.27M
Last updated: Nov 17, 2026 at 4:38 PM ET
Immuneering Corp (IMRX) Stock Chart
Immuneering (IMRX) has a latest price of $3.46 on Nov 17, 2026, 59.2% below its 52-week high of $8.48. Its price fell 45.5% over the past 12 months. The month-end price fell 86.2% over the 5 years through Oct 2026, a compound annual decline of 32.7%.
Price Chart
From Jul 2021 to Oct 2026, its highest month-end close was $27.10 in Oct 2021 and its lowest $1.11 in Aug 2024, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart IMRX with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for IMRX.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 35.1%, and over 6 months it fell 29.2%. The month-end price fell 46.7% over the 3 years through Oct 2026, a compound annual decline of 18.9%.
| Period | Change |
|---|---|
| 1 month | -5.5% |
| 3 months | -35.1% |
| 6 months | -29.2% |
| 12 months | -45.5% |
| 12 months, with dividends | -45.5% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -46.7% | -18.9% |
| 5 years | -86.2% | -32.7% |
Price by Year
Its best calendar year was 2025, when the price rose 199.1%, and its weakest was 2024, when it fell 70.1%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $3.75 | -43.1% |
| 2025 | $6.58 | +199.1% |
| 2024 | $2.20 | -70.1% |
| 2023 | $7.35 | +51.5% |
| 2022 | $4.85 | -70.0% |
Trading Range
The price is 12.3% below its 50-day average of $3.94 and 26.9% below its 200-day average of $4.73.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $3.46 | |
| 52-week high | $8.48 | -59.2% |
| 52-week low | $3.35 | +3.3% |
| 50-day average | $3.94 | -12.3% |
| 200-day average | $4.73 | -26.9% |
Price Risk
Over 3 years, its largest fall from a peak was 87.8%.
| Measure | Value |
|---|---|
| 1-year beta | 1.37 |
| Largest fall, 1 year | -59.5% |
| Largest fall, 3 years | -87.8% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About IMRX
What is IMRX's 1-year price change?
Immuneering's price fell 45.5% over the past 12 months. With dividends included, the 12-month total return was -45.5%.
What is IMRX's 5-year price change?
Immuneering's month-end price fell 86.2% over the 5 years through Oct 2026, a compound annual decline of 32.7%. These figures leave out dividends.
What is IMRX's 52-week high and low?
Immuneering's 52-week high is $8.48 and its 52-week low is $3.35. Its latest price of $3.46 on Nov 17, 2026 is 59.2% below the high.
What is IMRX's beta?
Immuneering's 1-year beta against the S&P 500 is 1.37, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 59.5%.
Is the IMRX chart free?
Yes. Advanced Charting for IMRX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
IMRX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors